Company / Return on Assets (ROA)
Kura Oncology, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-37.7%
FY2025
5-year range
-37.7% / -22.9%
FY2021-FY2025
Trend
-64.9%
vs FY2024
Sector context
#152 of 213
Health Care
What the data says
At -37.7%, Kura Oncology, Inc.'s return on assets (roa) ranks #152 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -39.5% in FY2016 to -13.9% in FY2020.
Based on SEC 10-K filings.
-37.7% in FY2025 with a 5-year CAGR of -23.9%.
Declined from -34.0% to -37.7% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -8.0pp
- 5-Year Change
- -23.9pp
- 10-Year Change
- -
Sector benchmark
#152 of 213 in Health CareTop 71% of 213This company -37.7% Sector average -24.1%
▼
-56.3% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 64.9% year-over-year.
- Currently 13.6pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -37.7% | -64.9% |
| FY2024 | -22.9% | +32.7% |
| FY2023 | -34.0% | -14.2% |
| FY2022 | -29.8% | -21.9% |
| FY2021 | -24.4% | -76.4% |
| FY2020 | -13.9% | +46.9% |
| FY2019 | -26.1% | +21.3% |
| FY2018 | -33.1% | +10.4% |
| FY2017 | -37.0% | +6.3% |
| FY2016 | -39.5% | -52.2% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026